Table 4.
Group | Time | β | SE | LSM | SE | 95% CI | |
---|---|---|---|---|---|---|---|
Cognitive/Affective | 1 | 1.65 | 0.04 | 5.20 | 0.21 | 4.79 | 5.63 |
2 | 1.80 | 0.05 | 6.03 | 0.28 | 5.51 | 6.59 | |
3 | 1.84 | 0.05 | 6.29 | 0.32 | 5.69 | 6.95 | |
4 | 1.85 | 0.05 | 6.34 | 0.35 | 5.70 | 7.06 | |
Multiple morbidity | 1 | 1.60 | 0.03 | 4.96 | 0.15 | 4.66 | 5.27 |
2 | 1.74 | 0.03 | 5.71 | 0.18 | 5.38 | 6.07 | |
3 | 1.78 | 0.03 | 5.94 | 0.20 | 5.56 | 6.35 | |
4 | 1.81 | 0.04 | 6.11 | 0.22 | 5.70 | 6.56 | |
Osteoporosis | 1 | 1.61 | 0.03 | 4.98 | 0.16 | 4.67 | 5.31 |
2 | 1.78 | 0.03 | 5.90 | 0.20 | 5.53 | 6.31 | |
3 | 1.78 | 0.04 | 5.92 | 0.22 | 5.51 | 6.36 | |
4 | 1.79 | 0.04 | 5.98 | 0.24 | 5.53 | 6.46 | |
Vascular | 1 | 1.60 | 0.03 | 4.98 | 0.15 | 4.68 | 5.29 |
2 | 1.80 | 0.03 | 6.05 | 0.21 | 5.66 | 6.47 | |
3 | 1.76 | 0.04 | 5.83 | 0.22 | 5.42 | 6.28 | |
4 | 1.82 | 0.04 | 6.20 | 0.25 | 5.73 | 6.70 | |
Cancer | 1 | 1.57 | 0.03 | 4.81 | 0.14 | 4.54 | 5.10 |
2 | 1.73 | 0.03 | 5.64 | 0.18 | 5.30 | 6.00 | |
3 | 1.83 | 0.04 | 6.25 | 0.23 | 5.83 | 6.71 | |
4 | 1.76 | 0.04 | 5.80 | 0.22 | 5.39 | 6.25 | |
Minimal disease | 1 | 1.59 | 0.03 | 4.89 | 0.14 | 4.63 | 5.17 |
2 | 1.73 | 0.03 | 5.64 | 0.16 | 5.35 | 5.96 | |
3 | 1.76 | 0.03 | 5.84 | 0.18 | 5.50 | 6.20 | |
4 | 1.77 | 0.03 | 5.89 | 0.19 | 5.53 | 6.28 | |
Results for type III test of fixed effects | |||||||
Group | Time | Group x time interaction | |||||
F = 1.33, p = .25 | F = 331.36, p < .001* | F = 2.46, p = .001* |
Note. ADL = activities of daily living, LSM = least squares mean.